Literature DB >> 8444435

Correlates of patterns of substance abuse among patients with schizophrenia.

B J Cuffel1, K A Heithoff, W Lawson.   

Abstract

OBJECTIVE: Most previous research on substance abuse among patients with schizophrenia has not considered the types of substances abused or the confounding influences of polysubstance abuse. The authors' goals were to identify patterns of substance abuse among a sample of subjects with schizophrenia and to determine demographic and clinical correlates of these patterns.
METHODS: Subjects with schizophrenia were identified from the Epidemiologic Catchment Area study data base, which also provided information on the types of substances abused and on selected demographic and clinical characteristics. Latent class analysis was used to group subjects based on their patterns of substance abuse. Logistic regression was used to identify demographic and clinical correlates of the patterns.
RESULTS: Three latent classes based on patterns of substance abuse were identified: no substance abuse, abuse of alcohol and cannabis, and polysubstance abuse. Subjects with either of the two patterns of substance abuse were more likely to be younger and male and to have depressive symptoms.
CONCLUSIONS: The results do not support a link between abuse of specific substances and specific clinical symptoms but do suggest a general link between substance abuse and affective disturbance among schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444435     DOI: 10.1176/ps.44.3.247

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  16 in total

Review 1.  Cannabis and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.

Authors:  Cheryl M Corcoran; David Kimhy; Arielle Stanford; Shamir Khan; Julie Walsh; Judy Thompson; Scott Schobel; Jill Harkavy-Friedman; Ray Goetz; Tiziano Colibazzi; Victoria Cressman; Dolores Malaspina
Journal:  Schizophr Res       Date:  2008-09-21       Impact factor: 4.939

3.  [Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city].

Authors:  T Schnell; K Neisius; J Daumann; E Gouzoulis-Mayfrank
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

Review 4.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

5.  Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.

Authors:  Thomas Wobrock; Helmut Sittinger; Bernd Behrendt; Roberto D'Amelio; Peter Falkai; Dieter Caspari
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-11-25       Impact factor: 5.270

6.  Comorbid substance use disorders in schizophrenia: a latent class approach.

Authors:  Berit Kerner
Journal:  Psychiatry Res       Date:  2014-12-15       Impact factor: 3.222

7.  Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health.

Authors:  S L Hedden; S S Martins; R J Malcolm; L Floyd; C E Cavanaugh; W W Latimer
Journal:  Drug Alcohol Depend       Date:  2009-09-15       Impact factor: 4.492

8.  Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia.

Authors:  Henk Temmingh; Ezra Susser; Sumaya Mall; Megan Campbell; Goodman Sibeko; Dan J Stein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-08-14       Impact factor: 4.328

9.  Comorbid substance abuse and brain morphology in recent-onset psychosis.

Authors:  Thomas Wobrock; Helmut Sittinger; Bernd Behrendt; Roberto D'Amelio; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-04       Impact factor: 5.270

10.  Should burden of disease estimates include cannabis use as a risk factor for psychosis?

Authors:  Louisa Degenhardt; Wayne D Hall; Michael Lynskey; John McGrath; Jennifer McLaren; Bianca Calabria; Harvey Whiteford; Theo Vos
Journal:  PLoS Med       Date:  2009-09-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.